Facciabene A - Search Results

1

Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA.

Mennuni C, Calvaruso F, Facciabene A, Aurisicchio L, Storto M, Scarselli E, Ciliberto G, La Monica N. Mennuni C, et al. Among authors: facciabene a. Int J Cancer. 2005 Nov 10;117(3):444-55. doi: 10.1002/ijc.21188. Int J Cancer. 2005. PMID: 15906358

2

A protocol to guide development of a sensitive ELISA for canine erythropoietin.

Giampaoli S, Facciabene A, Mennuni C. Giampaoli S, et al. Among authors: facciabene a. Vet Clin Pathol. 2003;32(4):199-201. doi: 10.1111/j.1939-165x.2003.tb00336.x. Vet Clin Pathol. 2003. PMID: 14655105

3

Baculovirus vectors elicit antigen-specific immune responses in mice.

Facciabene A, Aurisicchio L, La Monica N. Facciabene A, et al. J Virol. 2004 Aug;78(16):8663-72. doi: 10.1128/JVI.78.16.8663-8672.2004. J Virol. 2004. PMID: 15280475 Free PMC article.

4

DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection.

Facciabene A, Aurisicchio L, Elia L, Palombo F, Mennuni C, Ciliberto G, La Monica N. Facciabene A, et al. Hum Gene Ther. 2006 Jan;17(1):81-92. doi: 10.1089/hum.2006.17.81. Hum Gene Ther. 2006. PMID: 16409127

5

Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokines.

Giannetti P, Facciabene A, La Monica N, Aurisicchio L. Giannetti P, et al. Among authors: facciabene a. J Immunol Methods. 2006 Oct 20;316(1-2):84-96. doi: 10.1016/j.jim.2006.08.004. Epub 2006 Sep 14. J Immunol Methods. 2006. PMID: 17010367

6

CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge.

Elia L, Aurisicchio L, Facciabene A, Giannetti P, Ciliberto G, La Monica N, Palombo F. Elia L, et al. Among authors: facciabene a. Cancer Gene Ther. 2007 Feb;14(2):201-10. doi: 10.1038/sj.cgt.7701004. Epub 2006 Oct 20. Cancer Gene Ther. 2007. PMID: 17053815

7

Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects.

Facciabene A, Aurisicchio L, Elia L, Palombo F, Mennuni C, Ciliberto G, La Monica N. Facciabene A, et al. Vaccine. 2007 Dec 21;26(1):47-58. doi: 10.1016/j.vaccine.2007.10.060. Epub 2007 Nov 20. Vaccine. 2007. PMID: 18055074

8

Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.

Adams SF, Levine DA, Cadungog MG, Hammond R, Facciabene A, Olvera N, Rubin SC, Boyd J, Gimotty PA, Coukos G. Adams SF, et al. Among authors: facciabene a. Cancer. 2009 Jul 1;115(13):2891-902. doi: 10.1002/cncr.24317. Cancer. 2009. PMID: 19472394 Free PMC article.

9

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G. Buckanovich RJ, et al. Among authors: facciabene a. Nat Med. 2008 Jan;14(1):28-36. doi: 10.1038/nm1699. Epub 2008 Jan 6. Nat Med. 2008. PMID: 18157142

10

Endothelin B receptor, a new target in cancer immune therapy.

Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G. Kandalaft LE, et al. Among authors: facciabene a. Clin Cancer Res. 2009 Jul 15;15(14):4521-8. doi: 10.1158/1078-0432.CCR-08-0543. Epub 2009 Jun 30. Clin Cancer Res. 2009. PMID: 19567593 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters